Extensive Transduction and Enhanced Spread of a Modified AAV2 Capsid in the Non-human Primate CNS
Autor: | Kousaku Ohno, John Forsayeth, Amir Mahmoodi, Waldy San Sebastian, Amin Mahmoodi, Krystof S. Bankiewicz, Lamya S. Shihabuddin, Savanah Trewman, Jerusha Naidoo, Catherine R. O'Riordan, Piotr Hadaczek, Lisa M. Stanek, John Bringas, Jennifer Sullivan, Christopher Snieckus, Lluis Samaranch |
---|---|
Rok vydání: | 2018 |
Předmět: |
Central Nervous System
0301 basic medicine Nervous system Technology non-human primate Neurodegenerative Deep cerebellar nuclei Medical and Health Sciences Axonal Transport Transduction (genetics) Thalamus Parvovirinae Drug Discovery Motor Neurons Neurons nervous system viral vector Brain Gene Therapy Biological Sciences Dependovirus transduction Infusions Intraventricular medicine.anatomical_structure Spinal Cord Neurological Molecular Medicine Original Article Biotechnology Primates Infusions capsid modification Intraventricular brain Genetic Vectors Central nervous system Biology AAV vectors Viral vector 03 medical and health sciences CNS disorders Genetics medicine Animals Humans Molecular Biology Pharmacology Animal Neurosciences spinal cord Genetic Therapy Motor neuron Spinal cord Disease Models Animal 030104 developmental biology Disease Models Capsid Proteins Neuroscience Heparan Sulfate Proteoglycans |
Zdroj: | Molecular therapy : the journal of the American Society of Gene Therapy, vol 26, iss 10 |
ISSN: | 1525-0016 |
DOI: | 10.1016/j.ymthe.2018.07.008 |
Popis: | The present study was designed to characterize transduction of non-human primate brain and spinal cord with a modified adeno-associated virus serotype 2, incapable of binding to theheparan sulfate proteoglycan receptor, referred to as AAV2-HBKO. AAV2-HBKO was infused into the thalamus, intracerebroventricularly or via a combination of both intracerebroventricular and thalamic delivery. Thalamic injection of this modified vector encoding GFP resulted in widespread CNS transduction that included neurons in deep cortical layers, deep cerebellar nuclei, several subcortical regions, and motor neuron transduction in the spinal cord indicative of robust bidirectional axonal transport. Intracerebroventricular delivery similarly resulted in widespread cortical transduction, with one striking distinction that oligodendrocytes within superficial layers of the cortex were the primary cell type transduced. Robust motor neuron transduction was also observed in all levels of the spinal cord. The combination of thalamic and intracerebroventricular delivery resulted in transduction of oligodendrocytes in superficial cortical layers and neurons in deeper cortical layers. Several subcortical regions were also transduced. Our data demonstrate that AAV2-HBKO is a powerful vector for the potential treatment of a wide number of neurological disorders, and highlight that delivery route can significantly impact cellular tropism and pattern of CNS transduction. |
Databáze: | OpenAIRE |
Externí odkaz: |